Paradoxical abatement of striatal dopaminergic transmission by cocaine and methylphenidate

Journal of Biological Chemistry

Volumn 289, Issue 1, 2014, Pages 264-274

  Federici, Mauro ^a   Latagliata, Emanuele Claudio ^a,b   Ledonne, Ada ^a,c   Rizzo, Francesca R ^a   Feligioni, Marco ^e   Sulzer, Dave ^d   Dunn, Matthew ^d   Sames, Dalibor ^d   Gu, Howard ^f   Nisticò, Robert ^a,b   Puglisi Allegra, Stefano ^a,b   Mercuri, Nicola B ^a,c  

^a IRCCS FONDAZIONE SANTA LUCIA   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

^c UNIVERSITY OF ROME TOR VERGATA   (Italy)

^d Och Spine at New York Presbyterian Hospitals   (United States)

^e EUROPEAN BRAIN RESEARCH INSTITUTE   (Italy)

^f THE OHIO STATE UNIVERSITY COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOLOGY; MAMMALS; NEUROPHYSIOLOGY;

ATTENTION DEFICIT HYPERACTIVITY DISORDER; BEHAVIORAL EFFECTS; DOPAMINE TRANSPORTERS; INHIBITORY EFFECT; METHYLPHENIDATE; MICRO-DIALYSIS; OPTICAL ANALYSIS; PSYCHOSTIMULANTS;

MEDICAL PROBLEMS;

COCAINE; DOPAMINE; DOPAMINE TRANSPORTER; METHYLPHENIDATE; SYNAPSIN; DOPAMINE UPTAKE INHIBITOR;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BRAIN FUNCTION; BRAIN REGION; BRAIN SLICE; CONTROLLED STUDY; DOPAMINE RELEASE; DOPAMINERGIC TRANSMISSION; IN VITRO STUDY; MALE; MICRODIALYSIS; MOLECULAR DYNAMICS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; STRIATE CORTEX; WILD TYPE; ANIMAL; CORPUS STRIATUM; DRUG EFFECTS; EXOCYTOSIS; GENETICS; METABOLISM; PHOSPHORYLATION; SYNAPTIC TRANSMISSION;

ANIMALS; COCAINE; CORPUS STRIATUM; DOPAMINE; DOPAMINE UPTAKE INHIBITORS; EXOCYTOSIS; METHYLPHENIDATE; MICE; PHOSPHORYLATION; SYNAPSINS; SYNAPTIC TRANSMISSION;

EID: 84891683612     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M113.495499     Document Type: Article

References (40)

1. Koob, G. F., and Bloom, F. E. (1988) Cellular and molecular mechanisms of drug dependence. Science 242, 715-723
2. Kuhar, M. J., Ritz, M. C., and Boja, J. W. (1991) The dopamine hypothesis of the reinforcing properties of cocaine. Trends Neurosci. 14, 299-302
3. Chen, R., Han, D. D., and Gu, H. H. (2005) A triple mutation in the second transmembrane domain of mouse dopamine transporter markedly decreases sensitivity to cocaine and methylphenidate. J. Neurochem. 94, 352-359 (Pubitemid 40995251)
4. Penberthy, J. K., Ait-Daoud, N., Vaughan, M., and Fanning, T. (2010) Review of treatment for cocaine dependence. Curr. Drug Abuse Rev. 3, 49-62
5. Amalric, M., and Koob, G. F. (1993) Functionally selective neurochemical afferents and efferents of the mesocorticolimbic and nigrostriatal dopamine system. Prog. Brain Res. 99, 209-226 (Pubitemid 24015896)
6. Berke, J. D., and Hyman, S. E. (2000) Addiction, dopamine, and the molecular mechanisms of memory. Neuron 25, 515-532
7. Roitman, M. F., Wheelerm R. A., Wightman, R. M., and Carelli, R. M (2008). Real-time chemical responses in the nucleus accumbens differentiate rewarding and aversive stimuli. Nat. Neurosci. 11, 1376-1377
8. Bradberry, C. W. (2008) Comparison of acute and chronic neurochemical effects of cocaine and cocaine cues in rhesus monkeys and rodents. Focus on striatal and cortical dopamine systems. Rev. Neurosci. 19, 113-128
9. Kalivas, P. W., and Volkow, N. D. (2005) The neural basis of addiction. A pathology of motivation and choice. Am. J. Psychiatry 162, 1403-1413 (Pubitemid 41105554)
10. Geracitano, R., Paolucci, E., Prisco, S., Guatteo, E., Zona, C., Longone, P., Ammassari-Teule, M., Bernardi, G., Berretta, N., and Mercuri N. B. (2003) Altered long-term corticostriatal synaptic plasticity in transgenic mice overexpressing human CU/ZN superoxide dismutase (GLY (93) 3ALA) mutation. Neuroscience 118, 399-408 (Pubitemid 36423255)
11. Napolitano, F., Bonito-Oliva, A., Federici, M., Carta, M., Errico, F., Magara, S., Martella, G., Nisticò, R., Centonze, D., Pisani, A., Gu, H. H., Mercuri, N. B., and Usiello, A. (2010) Role of aberrant striatal dopamine D1 receptor/cAMP/protein kinase A/DARPP32 signaling in the paradoxical calming effect of amphetamine. J. Neurosci. 30, 11043-11056
12. Pittaluga, A., Feligioni, M., Longordo, F., Luccini, E., and Raiteri, M. (2006) Trafficking of presynaptic AMPA receptors mediating neurotransmitter release. Neuronal selectivity and relationships with sensitivity to cyclothiazide. Neuropharmacology 50, 286-296 (Pubitemid 43184357)
13. Rodriguez, P. C., Pereira, D. B., Borgkvist, A., Wong, M. Y., Barnard, C., Sonders, M. S., Zhang, H., Sames, D., and Sulzer, D. (2013) A fluorescent dopamine tracer resolves individual dopaminergic synapses and their activity in the brain. Proc. Natl. Acad. Sci. U. S. A. 110, 870-875
14. Ventura, R., Morrone, C., and Puglisi-Allegra, S. (2007) Prefrontal/accumbal catecholamine system determines motivational salience attribution to both reward- and aversion-related stimuli. Proc. Natl. Acad. Sci. U. S. A. 104, 5181-5186 (Pubitemid 47186196)
15. Federici, M., Geracitano, R., Bernardi, G., and Mercuri, N. B. (2005) Actions Actions of methylphenidate on dopaminergic neurons of the ventral midbrain. Biol. Psychiatry 57, 361-365 (Pubitemid 40215765)
16. Ruetsch, Y. A., Böni, T., and Borgeat, A. (2001) From cocaine to ropivacaine. The history of local anesthetic drugs. Curr. Top. Med. Chem. 1, 175-182
17. Dackis, C. A., and Gold, M. S. (1985) New concepts in cocaine addiction. The dopamine depletion hypothesis. Neurosci. Biobehav. Rev. 9, 469-477 (Pubitemid 16243388)
18. Venton, B. J., Seipel, A. T., Phillips, P. E., Wetsel, W. C., Gitler, D., Greengard, P., Augustine, G. J., and Wightman, R. M. (2006) Cocaine increases dopamine release by mobilization of a synapsin-dependent reserve pool. J. Neurosci. 26, 3206-3209
19. Grace, A. A. (1991) Phasic vs. tonic dopamine release and the modulation of dopamine system responsivity. A hypothesis for the etiology of schizophrenia. Neuroscience 41, 1-24
20. Grace, A. A. (1995) The tonic/phasic model of dopamine system regulation. Its relevance for understanding how stimulant abuse can alter basal ganglia function. Drug Alcohol Depend. 37, 111-129
21. John, C. E., and Jones, S. R. (2007) Voltammetric characterization of the effect of monoamine uptake inhibitors and releasers on dopamine and serotonin uptake in mouse caudate-putamen and substantia nigra slices. Neuropharmacology 52, 1596-1605 (Pubitemid 46843135)
22. Yorgason, J. T., España, R. A., and Jones, S. R. (2011) Demon voltammetry and analysis software. Analysis of cocaine-induced alterations in dopamine signaling using multiple kinetic measures. J. Neurosci. Methods 202, 158-164
23. Hunt, P., Kannengiesser, M., and Raynaud, J. (1974) Nomifensine. A new potent inhibitor of dopamine uptake into synaptosomes from rat brain corpus striatum. J. Pharm. Pharmacol. 26, 370-371
24. Tella, S. R., Ladenheim, B., and Cadet, J. L. (1997) Differential regulation of dopamine transporter after chronic self-administration of bupropion and nomifensine. J. Pharmacol. Exp. Ther. 281, 508-513 (Pubitemid 27203109)
25. Refahi-Lyamani, F., Saadouni, S., Costentin, J., and Bonnet, J. J. (1995) Interaction of two sulfhydryl reagents with a cation recognition site on the neuronal dopamine carrier evidences small differences between [3H]GBR 12783 and [3H]cocaine binding sites. Naunyn-Schmiedeberg's Arch. Pharmacol. 351, 136-145
26. Sulzer, D. (2011) How addictive drugs disrupt presynaptic dopamine neurotransmission. Neuron 69, 628-649
27. Floor, E., Leventhal, P. S., and Schaeffer, S. F. (1990) Partial purification and characterization of the vacuolar H'-ATPase of mammalian synaptic vesicles. J. Neurochem. 55, 1663-1670
28. Parsons, T. D., Coorssen, J. R., Horstmann, H., Lee, A. K., Tse, F. W., and Almers, W. (1995). The last seconds in the life of a secretory vesicle. Cold Spring Harbor Symp. Quant. Biol. 60, 389-396 (Pubitemid 26202049)
29. Zheng, F., and Zhan, C. G. (2012) Modeling of pharmacokinetics of cocaine in human reveals the feasibility for development of enzyme therapies for drugs of abuse. PLoS Comput. Biol. 8, 1-10
30. Zimmer, B. A., Dobrin, C. V., and Roberts, D. C. (2011) Brain-cocaine concentrations determine the dose self-administered by rats on a novel behaviorally dependent dosing schedule. Neuropsychopharmacology 36, 2741-2749
31. Balcioglu, A., Ren, J. Q., McCarthy, D., Spencer, T. J., Biederman, J., and Bhide, P. G. (2009) Plasma and brain concentrations of oral therapeutic doses of methylphenidate and their impact on brain monoamine content in mice. Neuropharmacology 57, 687-693
32. Bystrowska, B., Adamczyk, P., Moniczewski, A., Zaniewska, M., Fuxe, K., and Filip, M. (2012) LC/MS/MS evaluation of cocaine and its metabolites in different brain areas, peripheral organs and plasma in cocaine self-administering rats. Pharmacol. Rep. 64, 1337-1349
33. Couper, F. J., and Logan, B. K. (2004). Drugs and Human Performance Fact Sheets, pp. 20-21, National Highway Traffic Safety Administration, Washington, D. C.
34. George, F. R., and Ritz, M. C. (1990) Cocaine produces locomotor stimulation in SS but not LS mice. Relationship to dopaminergic function. Psychopharmacology 101, 18-22 (Pubitemid 20124735)
35. Marley, R. J., Arros, D. M., Henricks, K. K., Marley, M. E., and Miner, L. L. (1998) Sensitivity to cocaine and amphetamine among mice selectively bred for differential cocaine sensitivity. Psychopharmacology 140, 42-51 (Pubitemid 28524306)
36. Rocha, B. A., Scearce-Levie, K., Lucas, J. J., Hiroi, N., Castanon, N., Crabbe, J. C., Nestler, E. J., and Hen, R. (1998) Increased vulnerability to cocaine in mice lacking the serotonin-1B receptor. Nature 393, 175-178 (Pubitemid 28242258)
37. Bardo, M. T., Neisewander, J. L., Kelly, T. H. (2013) Individual differences and social influences on the neurobehavioral pharmacology of abused drugs. Pharmacol. Rev. 65, 255-290
38. Gulley, J. M., Hoover, B. R., Larson, G. A., Zahniser, N. R. (2003) Individual differences in cocaine-induced locomotor activity in rats. Behavioral characteristics, cocaine pharmacokinetics, and the dopamine transporter. Neuropsychopharmacology 28, 2089-2101 (Pubitemid 37468177)
39. Sabeti, J., Gerhardt, G. A., Zahniser, N. R. (2002) Acute cocaine differentially alters accumbens and striatal dopamine clearance in low and high cocaine locomotor responders. Behavioral and electrochemical recordings in freely moving rats. J. Pharmacol. Exp. Ther. 302, 1201-1211 (Pubitemid 34920244)
40. Briegleb, S. K., Gulley, J. M., Hoover, B. R., Zahniser, N. R. (2004) Individual differences in cocaine- and amphetamine-induced activation of male Sprague-Dawley rats. Contribution of the dopamine transporter. Neuropsychopharmacology 29, 2168-2179 (Pubitemid 39578907)